TY - JOUR
T1 - Alcohol use in patients with chronic liver disease
AU - Fuster, Daniel
AU - Samet, Jeffrey H.
PY - 2018/9/27
Y1 - 2018/9/27
N2 - Copyright © 2018 Massachusetts Medical Society. Globally, alcohol consumption is the seventh leading risk factor for both death and the burden of disease and injury.1 Alcohol use accounts for 6.8% of age-standardized deaths in men and 2.2% in women, with a disproportionate effect on young people.1 The overall costs associated with alcohol use represent more than 1% of the gross national product in high-and middle-income countries, with the costs of social harm (e.g., violence and road accidents) being far greater than health costs alone.2 In short, except for tobacco, alcohol accounts for a higher burden of disease than any other drug.3 In this review, we discuss the effects of alcohol use on various forms of liver disease, as well as the assessment and treatment of alcohol use in patients with chronic liver disease.
AB - Copyright © 2018 Massachusetts Medical Society. Globally, alcohol consumption is the seventh leading risk factor for both death and the burden of disease and injury.1 Alcohol use accounts for 6.8% of age-standardized deaths in men and 2.2% in women, with a disproportionate effect on young people.1 The overall costs associated with alcohol use represent more than 1% of the gross national product in high-and middle-income countries, with the costs of social harm (e.g., violence and road accidents) being far greater than health costs alone.2 In short, except for tobacco, alcohol accounts for a higher burden of disease than any other drug.3 In this review, we discuss the effects of alcohol use on various forms of liver disease, as well as the assessment and treatment of alcohol use in patients with chronic liver disease.
U2 - 10.1056/NEJMra1715733
DO - 10.1056/NEJMra1715733
M3 - Review article
C2 - 30257164
SN - 0028-4793
VL - 379
SP - 1251
EP - 1261
JO - New England Journal of Medicine
JF - New England Journal of Medicine
IS - 13
ER -